70.50EUR-2.22%Mkt Cap: 819.54M EURP/E: 14.27Last update: 2026-06-01
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offer…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap819.54M EUR
Enterprise Value632.24M EUR
Revenue (TTM)525.69M EUR
Gross Profit392.83M EUR
Net Income (TTM)57.36M EUR
Revenue/Share45.23 EUR
Last Price70.50 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0004186856
Valuation
P/E (Trailing)14.27
P/E (Forward)12.78
PEG3.80
EV/EBITDA6.11
EV/Revenue1.20
P/S1.59
P/B1.50
EPS (TTM)4.94
EPS (Forward)5.64
52W Range
68.708% of range91.50
52W High91.50 EUR
52W Low68.70 EUR
Profitability
Gross Margin74.73%
Oper. Margin16.82%
EBITDA Margin19.68%
Profit Margin10.91%
ROE9.70%
ROA7.51%
Growth
Revenue Growth-2.40%
Earnings Growth-5.10%
Cash Flow & Leverage
Operating CF72.08M EUR
CapEx (TTM)20.73M EUR
FCF Margin9.26%
FCF Yield5.94%
Net Debt-205.78M EUR
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity0.03
Current Ratio3.08
Quick Ratio2.21
Book Value/Sh48.21 EUR
Cash/Share19.02 EUR
Dividends
Fwd Div Rate0.9300 EUR
Trail. Div Rate0.9300 EUR
Div. Yield1.28%
5Y Avg Yield0.85%
Payout Ratio18.02%
Ex-Div DateJun 3, 2026
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)90.38 EUR
Target Range80.00 EUR – 110.00 EUR
# Analysts4
Ownership
Shares Out.11.62M
Float3.65M
Insiders67.01%
Institutions13.37%
Technical
SMA 5076.92 (-8.3%)
SMA 20078.63 (-10.3%)
Beta0.90
S&P 52W Chg27.94%
Avg Vol (30d)3.24K
Avg Vol (10d)4.35K
Technical Indicators
RSI (14)39.3
MACD-1.4976
MACD Signal-1.7219
MACD Hist.+0.2243
BB Upper75.61 EUR
BB Middle72.87 EUR
BB Lower70.13 EUR
BB Width7.53%
ATR (14)1.630 EUR
Vol Ratio (20d)0.70x